Search results
Stem cell transplants and survival rates on the rise across all racial and ethnic groups
Medical Xpress· 4 days agoThe volume of hematopoietic cell transplants rose among all racial/ethnic groups, but grew faster...
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric...
Fort Wayne Journal Gazette· 6 days agoNovartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera®...
Ramona kindergartener fighting leukemia gets a dream Make-A-Wish day
U-T San Diego· 6 days agoKindergartener Elizabeth “Lizzie” Grant loves her family, her friends and her pets. Two of those...
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $34.42 Average PT from Brokerages
ETF DAILY NEWS· 5 days agoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has been given an average rating of “Moderate Buy” by the ten research firms that are covering the stock, Marketbeat Ratings reports ...
Young girl survives cancer thanks to little sister’s lifesaving donation: 'A perfect match'
Fox News· 6 days agoA young girl in the U.K. is in cancer remission thanks to her sister’s lifesaving bone marrow...
A military vet's Parkinson's battle, plus AI's role in cancer care and a mother's fight
Fox News· 5 days agoThe Fox News Health Newsletter brings you trending and important stories about health warnings, drug...
IN8bio, Inc. (NASDAQ:INAB) Expected to Earn Q1 2024 Earnings of ($0.15) Per Share
ETF DAILY NEWS· 4 days agoIN8bio, Inc. (NASDAQ:INAB – Free Report) – Stock analysts at Zacks Small Cap issued their Q1 2024 earnings per share (EPS) estimates for IN8bio in a report issued on Monday, April 22nd. Zacks ...
Kura Oncology, Inc. (NASDAQ:KURA) Stock Holdings Lessened by Mirae Asset Global Investments Co. Ltd.
ETF DAILY NEWS· 4 days agoMirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
Kura Oncology (NASDAQ:KURA) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 6 days agoKura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research note issued on Monday, Benzinga reports. HC Wainwright ...